Monday, August 24, 2009

FDA's Mercury Ruling Defies ALL Scientific Reasoning

In the video above I speak with Charles Brown, legal counsel for the Consumers for Dental Choice, which is a nonprofit corporation whose purpose is to educate the public about the health and environmental dangers of mercury fillings, and to ensure more effective government oversight on amalgam. Charles discusses the processes he's been undertaking for the last 10 years to get dangerous mercury fillings removed from the market, and brings you up to speed on where we are today with the FDA's most recent, atrocious ruling.

The U.S. FDA has issued a final regulation classifying dental amalgam without calling for stringent precautions for pregnant women and children -- even though last June a court settlement filed by the Consumers for Dental Choice required the FDA to withdraw claims of mercury amalgam's safety from its Web site and issue an advisory indicating:

"Dental amalgams contain mercury, which may have neurotoxic effects on the nervous systems of developing children and fetuses."

Instead, the FDA has classified the fillings as class II devices, meaning the agency is claiming that they are completely harmless. This stands in direct contradiction of the conclusions of the FDA's own panel of scientific experts, and the findings of the International Academy of Oral Medicine and Toxicology (IAOMT).

In fact, mercury dental fillings contribute 2 to 3 times as much mercury to the human body as all dietary and environmental sources combined. IAOMT is urging the FDA to change the ruling, ban dental amalgam from commerce and issue a mandatory recall on the product.

Charles Brown says:

"FDA broke its contract and broke its word that it would put warnings for children and unborn children for neurological damage. Bowing to the dental products industry, FDA for the first time in its history pulled a warning about neurological harm to children."

"This contemptuous attitude toward children and the unborn will not go unanswered," said Brown.  "We will see FDA in court."

No comments: